“Incorporating the 40-Gene Expression Profile (40-GEP) Test within Each Clinicopathologic Staging System Improves Metastatic Risk-Stratification in Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) and One or More High Risk Factors” (2024) SKIN The Journal of Cutaneous Medicine, 8(1), p. s334. doi:10.25251/skin.8.supp.334.